MedTrace Logo

Bariatric Surgery-Induced Shift in Gut Microbiome and NAFLD

NCT04263376 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2023-01-05

No results posted yet for this study

Summary

This study is designed as a prospective pilot study for longitudinal assessment of fecal microbiome related to medical and surgical weight loss. The investigators follow the standard of care for perioperative and intraoperative management of study participants. The only addition to the standard of care protocol will be collection of fecal samples at 3 time points. This will enable investigators to compare changes in and effects by microbiota after low-calorie diet versus after bariatric surgery .

Conditions

  • Obesity
  • Diabetes Mellitus, Type 2
  • NAFLD

Sponsors & Collaborators

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Ali Aminian, MD · The Cleveland Clinic

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-24
Primary Completion
2022-01-31
Completion
2022-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04263376 on ClinicalTrials.gov